News / All News / Article

Penguin On Site | Weiming Penguin & Tencent Cloud Conclude Their AI for Pharmaceutical Industry Applications Exchange at Tencent Binhai Towers, Exploring New Paths to Industry Digital Upgrading

Article images may contain Chinese text.

Image

On December 4, 2025, the “Weiming Penguin & Tencent Cloud Exchange on AI-Driven Growth for Pharmaceutical Manufacturers and Business Applications of 2025 AI Product Upgrades (Weiming Penguin · Intelligent Insights, Shenzhen)” jointly hosted by Weiming Penguin and Tencent Cloud was successfully held at Tencent Binhai Towers. Focusing on the deep integration of AI and pharmaceutical operations, the event brought together industry experts and company representatives to explore practical paths to pharmaceutical digital upgrading and help pharmaceutical companies harness AI technologies to overcome growth challenges.


A Major Opening
Image
Image

Starting at 11:00 that day, guests checked in and, guided by Weiming Penguin staff, proceeded to Tencent Binhai Towers for an orderly tour of the Tencent exhibition hall, getting an early taste of the innovative atmosphere where technology meets pharmaceuticals.
Image


Dr. Zou Xiaoliang, Founder & CEO of Weiming Penguin, began by thanking the guests. Citing industry perspectives, he noted that artificial intelligence (AI) has become a trend toward a paradigm revolution far exceeding that of the internet. He then compared AI development in China and the United States, emphasizing China’s distinctive advantage in the way industries actively embrace AI and explore the deep integration of technology and business. This, he said, was the central purpose of bringing everyone together at Tencent Binhai Towers: to spark cross-disciplinary exchanges and in-depth discussions and jointly identify practical paths to digital and intelligent upgrading in the pharmaceutical industry. He said that Weiming Penguin has consistently focused on digital and intelligent transformation in the pharmaceutical and healthcare industry and understands that the industry needs not only cutting-edge technology but also application-specific implementation capabilities and ecosystem collaboration. By co-hosting the event with Tencent Cloud, the company hoped to combine Tencent’s extensive expertise in cloud computing, large models, and ecosystem connectivity with the pharmaceutical industry’s real needs, helping pharmaceutical companies overcome growth challenges and improve value across the entire chain, from data foundations to business applications.

Image

Dr. Zou Xiaoliang hoped attendees would use this opportunity to experience firsthand the atmosphere of internet technology integrating with industry and deepen their thinking and practice around AI. He also looked forward to further collaboration with ecosystem partners such as Tencent, turning the connections and inspiration from the event into AI applications with practical industry value and jointly opening new frontiers for high-quality development in the pharmaceutical and healthcare industry.

Image

Next, Bao Yujie, SaaS Channel Lead in Tencent Cloud’s “Chansheng” Department, delivered remarks. He said he had gained inspiration from speaking with Dr. Zou Xiaoliang, a senior Tencent alumnus—an “old penguin”—whose strong Tencent track record and entrepreneurial achievements deserved industry recognition. He also focused on the business challenges of AI + SaaS and expressed keen anticipation for the event’s themed presentations. He said candidly that he hoped to leverage Weiming Penguin’s platform and capabilities to connect strategic resources across companies and would visit interested participating partners for in-depth discussions in the future. He also acknowledged Weiming Penguin’s deep ties with Tencent and reiterated the importance of co-hosting the event to empower the pharmaceutical sector with AI.


Insightful Presentations
Image

The entire event was moderated by Tian Ying, Co-founder & President of Weiming Penguin. In her opening remarks, she explained the choice of a “closed-door, small-group, substance-focused” format: “We believe that real value comes from deep thinking, candid exchanges, and actionable steps. AI is now reshaping industries across the board. For pharmaceutical companies, however, what matters more than technological change is always how to bring technology back to the fundamentals of business—how to turn it into tangible efficiency, verifiable results, and sustainable growth. To that end, today’s presentations follow a clear implementation path that we call the ‘AI Value Pyramid’:”

  • At the base of the pyramid are “data and knowledge”
    . These are the soil in which intelligence grows. Without high-quality, structured data and knowledge systems, AI struggles to truly understand the industry and serve the business. We will explore how to build a trustworthy, usable data intelligence foundation.
  • In the middle of the pyramid are “models and platforms”
    . These are the engines of intelligence. This layer addresses how to integrate large models deeply with the industry and align technology platforms with enterprises’ actual circumstances.
  • At the top of the pyramid are “scenarios and applications”
    . This is where intelligence delivers value. Today, we will see how AI takes the form of individual agents and solutions, working in specific areas such as R&D, production, sales, and service to solve real pain points.

Progressing from “foundations” to “scenarios” and connecting “technology” with “business” is the practical path for pharmaceutical companies embracing AI. Next, experts from Tencent Cloud, Tencent Lexiang, and Weiming Penguin will give systematic presentations along this path. They bring not only forward-looking technological perspectives but also thinking and practices validated in the industry. We hope today’s exchanges will let everyone arrive with inspiration and leave with methods. Let us explore together how technology can truly serve people, industry, and the future of Healthy China.

Image


Jason, Senior Presales Architect for Intelligent Large Model Products at Tencent Cloud, presented “ADP Large Model Agents and Practical Application Scenarios.” He introduced Tencent Cloud’s end-to-end large model capabilities and its dual-track strategy of proprietary Hunyuan models and open-source large models. Its agent strategy spans three layers—ecosystem, development, and infrastructure—and its overall capabilities have been recognized through testing by China’s Ministry of Industry and Information Technology. He also detailed enterprise large model architecture and 100 implementation scenarios, focusing on five major agent scenarios in healthcare and three modes of agent development. He shared practical examples using RAG, workflow, and Agent approaches, including a health assistant and a Sinotrans DHL workflow.

Image

Ray, Senior Architect at Tencent Lexiang, presented “The Essential Path to an Intelligent Leap for Pharmaceutical Companies,” sharing practices and insights on building AI knowledge bases. He argued that the focus of large-model AI implementation has shifted to scenario-specific applications, calling knowledge bases the “core repository” of company-specific knowledge and the “new infrastructure” of the large model era, capable of turning a “document warehouse” into an “enterprise brain.” He also analyzed five typical knowledge management challenges facing pharmaceutical companies, introduced the multi-scenario integration of Lexiang knowledge bases with the WeCom ecosystem and its full-lifecycle management system, and proposed a three-part engine of intelligence: “knowledge bases + agents + large models.” He shared relevant practical cases and emphasized the service value of Tencent Lexiang’s 17 years of knowledge management experience.

Image

Figo, a Solutions Expert at Weiming Penguin, presented “AI Digital Capabilities for Pharmaceutical Companies and Healthcare Industry Implementation Cases.” He first outlined Weiming Penguin’s pharmaceutical digitalization blueprint and long-term service system, developed while serving more than 100 leading pharmaceutical and medical device clients. He then analyzed industry trends—including pharmaceutical companies’ greater emphasis on practical AI digitalization scenarios and the need to evaluate implementation results—and diverse application needs. He also introduced foundational applications such as AI knowledge bases and conversational data queries, along with six categories of typical AI agent cases, including automated data auditing and sales forecasting. Finally, he emphasized that data is central to AI applications and detailed the company’s comprehensive data resources, patented data cleansing technology, core products such as Zhongduantong®, and proprietary industry technology core.

Image

Viola, a Solutions Expert at Weiming Penguin, delivered presentations on “AI Knowledge Base Lifecycle Management Systems” and “Tencent Cloud BI Products.” During the presentations, she exchanged views with Xiao Junli, Information Director at Zhongzhi Pharmaceutical Group.

Image

In the AI knowledge base session, she first explained the industry significance of DeepSeek’s surge in popularity, outlined the “digitalization–centralization–intelligence” roadmap for enterprise knowledge management, and identified pharmaceutical companies’ pain points in question answering. Drawing on optimization cases at pharmaceutical companies, she then offered practical knowledge base optimization advice, including data structure improvements, and laid out a full-lifecycle management system featuring multidimensional classification and code management. In the Tencent Cloud BI session, she explained its end-to-end BI capabilities and advantages such as connectivity to multiple data sources. She also introduced Chat BI features including NL2DSL and intelligent attribution, along with recommendations for building conversational data query capabilities.

Image



Roundtable Forum
Image

To conclude the event, Kent, Vice President of Business Development at Weiming Penguin, moderated a roundtable on “AI-Powered Value Transformation—Breaking Through Barriers and Implementing Pharmaceutical Digital Upgrading.” Invited guests included Tan Guanghua, General Manager of Administration at Xiangxue Pharmaceutical; Liang Jian, Head of the Commercial and Multichannel Department at AbbVie Pharmaceutical Trading (Shanghai) Co., Ltd.; Xue Du, Head of Digitalization + AI at Livzon Group; Du Bobo, Head of Digitalization at Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.; Wang Wei, Head of General SaaS in Tencent Cloud’s “Chansheng” Department; and Cai Shufeng, General Manager of Hong Kong’s Luxembourg Medicine (Huaquan Pharmaceutical). The discussion focused on two core topics. First were the “iron triangle” challenges of implementing AI at pharmaceutical companies: starting with organization, data, and technology, guests examined critical gaps in technology capability building, data governance systems, and cross-department business collaboration across marketing, supply chains, innovative R&D, and other operations. Second was AI’s disruptive impact on pharmaceutical companies over the next 3–5 years. Participants predicted the direction of change in R&D, production, marketing, supply chains, and patient services and explained the underlying logic. The moderator also led interactive debates that generated numerous practical implementation insights.

Image

Weiming Penguin is joining forces with Tencent Cloud and Tencent Lexiang to build a collaborative healthcare ecosystem: using AI technology and ecosystem connectivity to develop full-lifecycle health services, with Tencent Cloud providing the digital foundation and Tencent Lexiang focusing on internal health management and collaboration efficiency within the industry, comprehensively covering consumer-facing services, technology infrastructure, and organizational management scenarios.
Image

Weiming Penguin is deeply engaged in integrating AI with the pharmaceutical and healthcare industry, focusing on pharmaceutical companies’ core digital and intelligent transformation needs. With end-to-end technology support and scenario-specific application capabilities at its core, it uses its AI Data Fusion Platform to strengthen the data processing foundation, creating a complementary approach with the Tencent ecosystem that combines “coverage of all scenarios” with “deep industry expertise.”

Image

The successful event not only created a platform for sharing technology resources between Weiming Penguin and Tencent Cloud but also gave pharmaceutical companies an opportunity to explore cutting-edge AI technologies up close and exchange practical experience. Choosing Weiming Penguin means gaining targeted technology support rooted in deep pharmaceutical industry expertise while also leveraging resource collaboration across the Tencent ecosystem’s full range of scenarios, with government and enterprises working together to reduce costs and improve efficiency for pharmaceutical companies. From data foundations to ecosystem implementation, this two-way support helps companies avoid detours in digital and intelligent transformation and jointly explore new frontiers for high-quality development in the healthcare industry.

WeChat_Image_20250316165946.jpg